IDiyas

For the Inventor, By the Inventor

Hertford, United Kingdom

Jeremy Peter Scott

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Harlow, GB (2007)
  • Hoddesdon, GB (2015 - 2016)
  • Hertfordshire, GB (2019 - 2020)
  • Hertford, GB (2008 - 2023)

Company Filing History:

goldMedal19 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal2 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal1 out of 123 
 
Astex Therapeutics Limited
 patents
4. 1 out of 262 
 
Cancer Research Technology Limited
 patents
where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12162883 - Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (2024-12-10),
2. 11603367 - Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them (2023-03-14),
3. 10526363 - Substituted phosphoramidate compounds and uses thereof (2020-01-07),
4. 10472345 - Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents (2019-11-12),
5. 10308633 - Process for making M1 receptor positive allosteric modulators (2019-06-04),
6. 9527855 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2016-12-27),
7. 9272999 - Crystalline polymorphic forms of an antidiabetic compound (2016-03-01),
8. 9242917 - Crystal forms of a HCV protease inhibitor (2016-01-26),
9. 9187488 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors (2015-11-17),
10. 9012488 - Crystalline polymorphic forms of an antidiabetic compound (2015-04-21),
11. 8697740 - Crystalline polymorphic forms of an antidiabetic compound (2014-04-15),
12. 7411088 - Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid (2008-08-12),
13. 7276637 - Synthesis of cyclohexanone derivatives (2007-10-02),

Title: Innovations and Contributions of Jeremy Peter Scott

Introduction

Jeremy Peter Scott is a notable inventor based in Hertford, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on the development of intermediates and inhibitors that have potential applications in medical treatments.

Latest Patents

One of his latest patents is titled "Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide." This invention relates to the preparation of protected piperidine carboxylates that serve as intermediates leading to the creation of a beta-lactamase inhibitor. Another significant patent is "Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them." This invention focuses on processes for preparing isoindolin-1-one derivatives, particularly those that inhibit the MDM2-P53 interaction, which is crucial in cancer research.

Career Highlights

Throughout his career, Jeremy has worked with prominent companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Jeremy has collaborated with esteemed colleagues, including John Y L Chung and Yanfeng Zhang. These partnerships have further enhanced his research capabilities and innovation potential.

Conclusion

Jeremy Peter Scott's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical treatments and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…